The ubiquitously expressed Raf-1 kinase serves as a central interface in mitogenic signalling networks that connect growth factor receptors to changes in gene expression in the nucleus (9, 20, 31, 50) . Raf-1 is activated by numerous growth factors, and impairment of its function blocks mitogenic stimulation as well as transformation by membrane-associated oncogenes such as ras (25, 26) . In the cell, Raf-1 can be activated by several modes, including phosphorylation by tyrosine kinases (23, 29) and protein kinase C (PKC) (3, 24, 43) . A major step of Raf-1 activation in the cell involves its translocation from the cytosol to the plasma membrane (27, 44) . This process is mediated by Ras proteins, which reside at the membrane and can bind Raf-1 with high affinity in their active, i.e., GTPloaded, state. This association occurs by interaction between the Ras effector domain and the Raf-1 amino-terminal domain (35) . This association does not activate Raf-1 directly but rather serves to expose Raf-1 to activating kinases and/or lipids located at the plasma membrane (12, 29) . Activated Raf-1 in turn phosphorylates and activates MEK, a kinase which phosphorylates and activates extracellular signal-regulated kinases/ mitogen-activated protein kinases (Erks/MAPKs) (9, 30) . MAPKs have a wide array of substrates, among them nuclear transcription factors (10) . The constitutive activation of this pathway (Ras 3 Raf 3 MEK 3 MAPK) suffices to transform NIH 3T3 cells, demonstrating its paramount role in regulation of cell proliferation (8) .
Several recent papers have reported that treatment of cells with ligands or drugs which elevate the cyclic AMP (cAMP) level disrupt signalling by the Ras 3 Raf 3 MEK 3 MAPK cascade (2, 7, 17, 19, 21, 42, 45, 52) . The second-messenger cAMP primarily leads to the activation of cAMP-dependent kinase (PKA). PKA is a tetramer consisting of two catalytic subunits and two regulatory subunits, which bind cAMP. As a consequence, the regulatory subunits dissociate and release the active catalytic subunits (32) . Besides activating PKA, cAMP is known to directly regulate ion channels and transporter proteins (33, 40, 48) . The block in Raf-1 signalling imposed by cAMP was mapped to occur at the level of Raf-1 activation or Raf-1 itself. In particular, we and others have shown that Raf-1 is a substrate for PKA in vitro. PKA-phosphorylated Raf-1 is severely compromised in its ability to bind Ras (5, 19, 52) . On the other hand, phosphorylation of Raf-1 by PKA in vitro directly inhibits the catalytic activity of Raf-1 (19) . Thus, three questions arise. First, does cAMP inhibit Raf-1 signalling in the cell by activation of PKA? Second, is the reduction of Ras-Raf-1 association responsible for the inhibitory effect of cAMP on Raf-1 signalling in the cell, or is it the direct impairment of the Raf-1 catalytic activity by PKA? Third, if the latter mechanism is relevant, what is the phosphorylation site responsible?
In this report, we have addressed these issues. Expression of the catalytic ␣ subunit of PKA (PKAcat) in insect and mammalian cells could fully reproduce the inhibitory effects of drugs which raise the cAMP levels in the cell, confirming that PKA is responsible for the inhibition of Raf-1. Using Raf-1 mutants which cannot bind Ras because of a point mutation of arginine 89 or deletion of the regulatory domain, we show that in the cell, the downregulation of Raf-1 kinase by PKA occurs independently of Ras. The inhibitory PKA phosphorylation site was mapped to serine 621 in the Raf-1 kinase domain. Serine 621 has been previously described as a constitutive phosphorylation site (37) . On the basis of the loss of activity of serine 621-to-alanine mutants, phosphorylation of this site was speculated to be required for Raf-1 kinase activity. The experiments presented here confirm that the integrity of arginine 618 and serine 621 is needed for activity but suggest that serine 621 also is a site of negative regulation. An increase in serine 621 phosphorylation correlates with downregulation of the catalytic activity, while dephosphorylation of serine 621 enhances activity.
MATERIALS AND METHODS
Plasmids and baculoviruses. The human Raf-1 cDNA was cloned into the pCMV5 vector as an EcoRI-BamHI fragment, in which they are expressed under the control of the cytomegalovirus promoter. Point mutants were generated by using a U.S.E. mutagenesis kit (Pharmacia). Mutations were confirmed by nucleotide sequencing. The pEFmycRaf plasmids were kindly provided by Chris Marshall. They contain a human Raf-1 cDNA tagged with the Myc epitope for monoclonal antibody 9E10 at the N terminus (mycRaf-1) and are expressed under the control of the elongation factor 1a promoter (29) . pSV2neoRas was kindly provided by Tom Shih (6) . An expression vector for mouse PKAcat (pCEV␣) (47) was a generous gift from Stanley McKnight. The cDNA from pCEV␣ was subcloned into the pVL1392 baculovirus vector in the laboratory of Martin Lohse, who kindly provided a PKA baculovirus stock. The construction of vectors for the expression of the glutathione S-transferase (GST)-tagged Raf-1 kinase domain, BXB, has been described (19) . BXB represents a mutant of Raf-1 in which most of the regulatory domain, including the Ras binding domain, has been removed by the deletion of amino acids (aa) 26 to 303 (1) . In addition, the start codon was changed to accommodate an NcoI site. The BXB cDNA was cloned in frame downstream of the GST portion of the Escherichia coli expression vector pGEX-KG (18) as an NcoI-SstI fragment and into the baculovirus transfer vector pGSTAcC5 (19) as an NcoI-XbaI fragment. The resulting construct was termed GNX. The pGSTAcC5 vector and baculovirus stocks for the RafS621D and RafK375W mutants were gifts of Gisela Heidecker.
Transient expression in COS-1 cells. COS-1 cells were grown in Dulbecco modified Eagle medium (DMEM; Serva) supplemented with glutamine and 10% fetal calf serum (Seromed). For transfection the cells were trypsinized, resuspended in DMEM containing 10% NU-serum (Collaborative Research catalog no. 55000), and plated in six-well plates at a confluency of 20 to 40%. Then 10 l of DC mix per ml was added, followed by 3 g of plasmid DNA. One hundred milliliters of DC mix contains 1.03 g of chloroquine phosphate (Sigma) and 8 g of DEAE-dextran (Sigma catalog no. D-9885). Four hours later, the medium was replaced by phosphate-buffered saline containing 10% dimethyl sulfoxide for 2 min. Then, cells were fed with DMEM plus 10% fetal calf serum. Under these conditions, protein expression increased linearly between 1 and 10 g of plasmid DNA transfected. Two days posttransfection, cells were deprived of serum overnight and treated as described in the figure legends.
Immunoprecipitation, Western blotting (immunoblotting), and immunocomplex kinase assays. Cells were lysed in 0.8 ml of TBST buffer (20 mM Tris HCl [pH 7.4], 150 mM NaCl, 2 mM EDTA, 1% Triton X-100) supplemented with protease inhibitors (1 mM phenylmethylsulfonyl fluoride and 1 g of leupeptin per ml) and phosphatase inhibitors (20 mM ␤-glycerophosphate, 2 mM sodium fluoride, and 2 mM sodium pyrophosphate). Lysates were cleared by centrifugation at 20,000 ϫ g for 10 min and incubated with 1.5 l of c-rafVII antiserum plus 10 l of protein A-agarose (Boehringer). mycRaf-1 proteins were immunoprecipitated with monoclonal antibody 9E10 coupled to protein G-Sepharose (Pharmacia) via a sheep anti-mouse bridge antibody (Boehringer). Immunoprecipitates were washed three times in TBST and once with Raf kinase buffer (20 mM Tris HCl [pH 7.4], 20 mM NaCl, 10 mM MgCl 2 , 1 mM dithiothreitol). Raf kinase reaction mixtures contained 100 ng of purified recombinant kinase-negative MEK (MEK Ϫ ) or, in the case of linked kinase assays, 50 ng of kinasecompetent MEK plus 150 ng of kinase-negative MAPK (MAPK Ϫ ), 2 M ATP, and 5 Ci of [␥-
32 P]ATP. After incubation for 30 min at 25ЊC, reactions were terminated by boiling in sodium dodecyl sulfate (SDS)-gel sample buffer, separated by SDS-gel electrophoresis, and transferred to a nitrocellulose membrane. The blot was autoradiographed and stained with the indicated antibodies as described previously (19) , using an ECL kit (Amersham) for detection.
Protein purification. The expression of proteins in Sf-9 insect cells was done as described previously (19) . A baculovirus transducing mouse PKAcat was kindly provided by Martin Lohse. Briefly, cells were lysed in TBST supplemented with protease and phosphatase inhibitors 3 days postinfection. The cleared lysates were immunoprecipitated as described above or incubated with 20 l of glutathione-Sepharose per ml to isolate the GST-tagged Raf-1 kinase domain, GNX. The beads were washed three times in TBST and once in Raf kinase buffer. GNX kinase activity was measured as described above with 100 ng of MEK Ϫ as the substrate. GNX produced in E. coli was purified as described above.
GNX phosphorylation and dephosphorylation. For autophosphorylation, GNX was eluted from the Sepharose beads with 10 mM glutathione (Sigma), diluted 1:5 in Raf kinase buffer containing 20 M ATP, and incubated at 25ЊC for the time points indicated in the legend to Fig. 5A . One-fifth of this reaction mixture was subsequently incubated with 100 ng of MEK Ϫ and 10 Ci of [␥-32 P]ATP for 30 min at 25ЊC to measure GNX catalytic activity. For the dephosphorylation experiment shown in Fig. 5C , one-fifth of the autophosphorylation reaction was incubated with 2.5 mU of protein phosphatase 1 (PP1) and 0.5 mU of PP2A for 30 min at 25ЊC. Protein phosphatases (PPs) were inactivated by addition of 2 M calyculin (Biomol), and substrate phosphorylation was measured as described above. To monitor autophosphorylation, GNX was incubated in Raf kinase buffer containing 2 M ATP and 10 Ci of [␥- 32 P]ATP for the same time points. GNX was gel purified, digested with trypsin, and subjected to two-dimensional phosphopeptide mapping. For phosphorylation-dephosphorylation experiments, GNX immobilized on glutathione-Sepharose was resuspended in 40 l of PKA kinase buffer (20 mM NaCl, 0.5 mM MnCl 2 , 0.1% Triton X-100, 0.1% 2-mercaptoethanol) and incubated with 5 mU of PP1 and 1 mU of PP2A for 30 min at 25ЊC. The recombinant catalytic subunit of PP1 was obtained from Boehringer; PP2A was from Upstate Biotechnology Inc. Between phosphorylation-dephosphorylation reactions, the GNX beads were washed twice with TBST and twice with the appropriate enzyme buffers. GNX was gel purified, digested with trypsin, and processed for two-dimensional phosphopeptide mapping.
High-pressure liquid chromatography (HPLC)-mass spectrometry (MS) analysis. Analysis was performed on an ABI Micropurification System 172 connected to a Berthold LB 507 HPLC radioactivity detector and subsequently to a PerkinElmer API 100 quadrupole mass spectrometer. GNX was phosphorylated with PKA in vitro and digested with sequencing-grade trypsin (Promega) as specified by the manufacturer. Tryptic peptides from 5 g of GNX were loaded onto a Pharmacia reverse-phase column. A gradient from 0 to 35% acetonitrile in 100 min and subsequently from 35 to 70% in 10 min was run at 40 l/min. Masses were determined in 0.1 amu steps over an m/z range from 300 to 2,000 with an orifice voltage of 20 V.
Two-dimensional peptide mapping. GNX was phosphorylated as described above, and bands of phosphorylated GNX were cut out from an SDS-gel, digested with trypsin, and processed for two-dimensional tryptic peptide mapping as described above, using pH 8.9 buffer for the first dimension and n-butanolpyridine-acetic acid-water (15/10/3/12) for the second dimension (19) .
RESULTS
Inactivation of Raf-1 by coexpression of the catalytic subunit of PKA. Previous studies have shown that the Raf-1 kinase can be inhibited by raising the cAMP levels in cells. This was accomplished by (i) stimulation of the muscarinic M1 receptor, which leads to the activation of adenylate cyclase; (ii) treatment of cells with pharmacological agents such as forskolin, which binds to and activates adenylate cyclase; (iii) prevention of cAMP hydrolysis by IBMX (3-isobutyl-1-methylxanthine); or (iv) use of membrane-permeable cAMP analogs such as 8-bromo-cAMP. cAMP activates PKA, and purified PKA can phosphorylate and inhibit the catalytic activity of Raf-1 in vitro (19) , suggesting that PKA activation is responsible for the reduction of Raf-1 kinase activity in the cell, albeit this point remains to be proven formally. Besides direct inhibition of the catalytic activity, PKA-phosphorylated Raf-1 is also compromised in its ability to bind Ras (5, 19, 52) , and both mechanisms may contribute to the attenuation of Raf-1 function in cells.
To dissect these possibilities, we expressed PKAcat alone or together with mycRaf-1 and mycRafR89L in COS-1 cells (Fig.  1 ). RafR89L is a point mutant at arginine 89 which is defective for Ras binding (16, 29) . If the reduction of Ras-Raf interaction is the decisive regulatory step imposed by PKA, the activity of the RafR89L mutant should not be susceptible to PKA inactivation. Cells were serum starved and subsequently stimulated with epidermal growth factor (EGF), tetradecanoyl phorbol acetate (TPA), or both agents. The mycRaf-1 proteins were immunoprecipitated with the Myc epitope-specific mono-clonal antibody 9E10, and their phosphotransferase activities were measured in a linked kinase assay. Neither mycRaf proteins nor kinase activity above the background level was recovered from vector control-transfected cells, demonstrating the specificity of antibody 9E10 (Fig. 1A ). TPA and EGF given individually or in combination robustly induced the kinase activity of both mycRaf-1 and mycRafR89L, albeit the extent of stimulation of mycRafR89L was very reproducibly less than of wild-type mycRaf-1 ( Fig. 1) . Cotransfection of v-ras resulted in a threefold stimulation of mycRaf but failed to induce mycRafR89L activity (Fig. 1B) , consistent with the deficiency of mycRafR89L to interact with Ras proteins. These observations suggest that the Raf-1 kinase activity can be regulated by pathways not involving Ras.
More importantly, coexpression of PKAcat inhibited the basal and especially the induced activities of both mycRaf-1 and mycRafR89L. These results demonstrate (i) that Raf-1 inhibition in the cell is indeed due to PKA and (ii) that the attenuation of Ras binding is dispensable for the downregulation of Raf-1 kinase activity by PKA. These data are consistent with our previous observation that the catalytic activity of the isolated Raf-1 kinase domain, which does not interact with Ras, can be inhibited by PKA phosphorylation in vitro (19) .
Identification of serine 621 as the PKA phosphorylation site in the Raf-1 kinase domain. PKA phosphorylates Raf-1 on several serine residues. One of these phosphorylation sites is located in the Raf-1 kinase domain (19) . Since we have previously shown that the isolated Raf-1 kinase domain is still susceptible to inhibition by PKA, this site must mediate the downregulation of the catalytic activity. To identify the phosphorylation site, the Raf-1 kinase domain, termed BXB, was expressed as a GST fusion protein (referred to as GNX) in E. coli and Sf-9 cells and subjected to phosphorylation with PKA in vitro. No phosphorylation of the GST portion was observed (see Fig. 3 ). Tryptic phosphopeptide maps revealed that PKA phosphorylated a single peptide in the GNX proteins purified from both E. coli and Sf-9 cells (Fig. 2A) . GNX expressed in E. coli was devoid of appreciable kinase and autophosphorylation activity. In contrast, GNX expressed in Sf-9 cells displayed autophosphorylation and substrate phosphorylation. Autophosphorylation occurred at the same site which was targeted by PKA, albeit to a much lesser extent. By the use of a GNX mutant, GNX-D, in which an internal StuI fragment was deleted, this phosphorylation site was mapped to the extreme N or C terminus of GNX.
This phosphorylated tryptic peptide was subsequently identified as SASEPSLHR (aa 619 to 627) by MS (Fig. 2B ). GNX purified from E. coli was radioactively labeled by phosphorylation with PKA, gel purified, and digested with trypsin. Tryptic peptides were separated by reverse-phase HPLC and analyzed on line in a radiodetector and subsequently an electrospray MS. The radioactivity was recovered in a single peak, which was examined for peptide masses. The mass of 1,064 Da identified for this peak corresponded to a singly phosphorylated form of the peptide SASEPSLHR (aa 619 to 627). The true mass of this peptide (984 Da) was increased by 80 Da, which represents the mass increase caused by addition of one phosphate group. To ascertain that this peptide indeed can serve as a PKA substrate, a peptide corresponding to aa 616 to 627 (INRSASEPSLHR) was synthesized. The inclusion of the additional amino acids at the N terminus was chosen to retain the consensus motif for PKA phosphorylation (R-X 1-3 -S/T), in particular the arginine at position 618. This peptide was efficiently phosphorylated by PKA in vitro. Tryptic digests of this peptide were separated by reverse-phase HPLC and compared with the elution profile of tryptic peptides generated from the GNX protein phosphorylated by PKA (Fig. 2C) . The synthetic peptide resolved into two major peaks, which probably are due to incomplete trypsin digestion. More importantly, however, the tryptic digest of GNX and the synthetic peptide exhibited single radioactive peaks whose elution profiles were superimposable, confirming that the main PKA phosphorylation site is located within aa 619 to 627.
This peptide contains three serine residues. Therefore, we changed these serines to alanines and expressed these mutants as GST fusion proteins in E. coli. Purified proteins were phosphorylated with PKA in vitro (Fig. 3) . The wild-type protein, termed GNX, lacked autokinase activity but was readily phosphorylated by PKA. Mutation of serine 621 virtually abolished phosphorylation by PKA, whereas the double mutants 619/624 was phosphorylated as efficiently as wild-type GNX. These experiments provided proof that PKA phosphorylates the Raf-1 kinase domain at serine 621.
The catalytic activity of Raf serine 621 mutants. Serine 621 has been described as a constitutive Raf-1 phosphorylation site, and mutation of this residue to alanine has been reported to result in the loss of Raf-1 kinase activity (37) . The identification of serine 621 as a PKA phosphorylation site demanded a reevaluation of this observation. Therefore, serine 621 was mutated to alanine, aspartic acid, or cysteine, or else arginine 618 was changed to phenylalanine in order to destroy the FIG. 1. Expression of PKAcat inhibits the Raf-1 kinase by a Ras-independent mechanism. COS-1 cells were transfected with 3 g of pEFRaf, pEFRafR89L, or empty vector. Where indicated, 3 g of a v-ras expression vector or pCEV␣, encoding the PKAcat, was cotransfected. Two days posttransfection, cells were serum starved (st.) overnight and stimulated with EGF (20 ng/ml), TPA (50 ng/ml), or both agents (TϩE) for 15 min. mycRaf proteins encoded by the pEF plasmids were immunoprecipitated with the Myc epitopespecific monoclonal antibody 9E10. Raf activity was determined in a coupled kinase assay using MEK and MAPK Ϫ as substrates. The reactions were resolved by electrophoresis on SDS-10% gels and blotted onto nitrocellulose. The blots were autoradiographed and stained with c-rafVII, using the ECL system. To visualize the basal activities of mycRaf proteins, the film shown in the right set of panel B was exposed longer. Substrate phosphorylation was quantitated with a Fuji PhosphorImager. The activity of mycRaf-1 was set to 1. Relative activities in panel A (beginning from the left), were 0.1, 0.2, 1, 0.7, 6.5, 2.1, 10.5, 2.9, 33.2, and 5.3. Those in panel B (left side, beginning from the left) were 0.9, 0.6, 4.8, 1.9, 6.9, 2.3, 21.5, 3.6, 2, 5.8, 1.9, and 1.8.
VOL. 16, 1996 Raf- (Fig. 4A) . For this purpose, Sf-9 cells were coinfected with various combinations of recombinant baculoviruses transducing GNX, PKC␣, or PKAcat. Three days postinfection, GNX was isolated by adsorption to glutathione-Sepharose beads and examined for kinase activity. Coexpression of PKC␣ stimulated GNX catalytic activity three-to fivefold. Simultaneous expression of PKA prevented the induction of GNX kinase activity by PKC␣. Similar results were obtained when GNX was activated by coexpression of the tyrosine kinase Lck (see Fig. 6A ) or when full-length Raf-1 was used instead of the truncated kinase domain (39) . These findings ensured that not only various modes of Raf-1 activation but also the inhibition of Raf-1 by PKA can be faithfully reproduced in Sf-9 cells. Thus, the kinase activity of RafS621D was compared with that of RafK375W, a mutant rendered kinase negative by exchange of the conserved lysine in the ATP binding site (25) . These mutants were expressed alone or together with PKC␣ or PKC␣ plus PKA, immunoprecipitated, and examined for kinase activity with MEK Ϫ as a substrate. The RafS621D protein possessed no detectable basal kinase activity but exhibited very weak activity when coexpressed with PKC␣. Importantly, the induced activity of RafS621D appeared resistant to downregulation by PKA. Consistent results were obtained when RafS621D immunoprecipitates were phosphorylated with purified PKC␣ or PKA in vitro. Phosphorylation with PKC␣ led to a weak stimulation of the RafS621D kinase activity, which could not be prevented by phosphorylation with PKA (39). Although we cannot strictly rule out that the low kinase activity associated with RafS621D was due to a contaminating kinase retained in the Raf immunoprecipitates, this possibility seems unlikely, because such an activity was not found in RafK375W immunoprecipitates. In addition, control experiments showed that neither PKA nor PKC␣ was able to phosphorylate MEK (39) . These data suggested that phosphorylation of serine 621 is involved in the downregulation of the Raf-1 kinase activity by PKA.
As serine 621 is suspected to be important for the structural integrity of the Raf-1 protein, the human Raf-1 cDNA was cloned into the pCMV5 expression vector, and additional mutants in this region were generated and expressed in COS-1 cells by transient transfection (Fig. 4B and C) . Where indicated, PKAcat was cotransfected and the cells were treated with EGF plus TPA prior to lysis. Raf-1 proteins were immunoprecipitated and examined for activity in a linked kinase assay. The activity seen in control cells transfected with the empty vector was due to precipitation of the endogenous Raf-1 protein. Typically, a 8-to 12-fold overexpression of the transfected mutants was achieved under the conditions used. Mutation of serine 621 to alanine or cysteine rendered the protein inactive. Likewise, changing arginine 618 to phenylalanine abolished kinase activity. In contrast, mutation of serine 619 to alanine did not significantly reduce the kinase activity and did not interfere with the regulation of Raf-1 by PKA. These data indicate that the disruption of the primary sequence elements, which also permit phosphorylation of serine 621, rather than structural alterations imposed by mutations within this domain, may be deleterious for Raf-1 function.
Regulation of Raf-1 kinase activity by phosphorylation of serine 621. Since the mutational analysis did not yield conclusive results as to the relevance of serine 621 phosphorylation for the regulation of Raf-1 kinase activity, we took a biochemical approach to evaluate whether the phosphorylation of serine 621 correlates with changes in catalytic activity (Fig. 5) .
If the hypothesis that serine 621 is a site of inhibitory phosphorylation is correct, an increase in the stoichiometry of serine 621 phosphorylation should be accompanied by a decrease in catalytic activity. The observation that GNX autophosphorylated exclusively on serine 621 ( Fig. 2A) suggested that GNX would autoinactivate upon prolonged incubation with ATP. Therefore, purified GNX was incubated under kinase conditions in the presence or absence of ATP. An aliquot of the autophosphorylation reaction mix was added to a reaction mix containing [␥-32 P]ATP and MEK Ϫ as the substrate to measure catalytic activity (Fig. 5A) . Parallel GNX samples were allowed to autophosphorylate in the presence of [␥-32 P] ATP and processed for tryptic phosphopeptide mapping in order to monitor the time course of serine 621 phosphorylation. GNX incubated without ATP stably retained the ability to phosphorylate substrate, whereas preincubation with ATP progressively reduced its phosphotransferase activity. According 
FIG. 2.
Mapping of the PKA phosphorylation site in the Raf-1 kinase domain to the peptide SASEPSLHR (aa 619 to 627). (A) Two-dimensional phosphopeptide maps of GNX expressed in Sf-9 insect cells or E. coli (E.c.). GNX was purified by affinity chromatography on glutathione-Sepharose and phosphorylated by PKA (a and d) or allowed to autophosphorylate (b). PKA phosphorylated one prominent peptide in GNX. GNX isolated from E. coli was devoid of kinase activity, while GNX purified from Sf-9 cells was active as MEK kinase and also displayed weak autokinase activity. Autophosphorylation occurred on the same peptide, which was phosphorylated by PKA (c) but never reached the extent of PKA phosphorylation. A GNX deletion mutant, GNX-D (g), which lacks an internal StuI fragment, yielded the same phosphorylation pattern as GNX (e and f), mapping the phosphorylation site to the extreme N or C terminus of the kinase domain. VOL. 16, 1996 Raf- to PhosphorImager quantitation, the GNX kinase activities of samples preincubated without ATP for 0 or 90 min differed by a factor of 0.99, whereas samples preincubated with ATP showed a 2.48-fold decrease in activity. The decrease in kinase activity between 20 and 90 min or 40 and 90 min was by a factor of 2.03 or 1.6, respectively. Two-dimensional phosphopeptide maps confirmed the phosphorylation of serine 621 and showed a time-dependent increase in the phosphorylation stoichiometry (Fig. 5B ), which correlated with the decrease in catalytic activity. Quantitation of these results by PhosphorImager analysis showed that autophosphorylation increased by factors of 3.95 between the 20-and 90-min time points and 2.09 between the 40-and 90-min time points. These values suggest that the decline in kinase activity was paralleled by an increase of serine 621 autophosphorylation in a nearly stoichiometric manner. Treatment of GNX, which had been allowed to autophosphorylate for 90 min, with a mixture of the serine/threonine-specific phosphatases PP1 and PP2A led to a recovery of kinase activity (Fig. 5C) , which was accompanied with dephosphorylation of serine 621 (Fig. 5D ). The extent of GNX reactivation exceeded the extent of inactivation by autophosphorylation Ϫ as the substrate. The kinase reaction mixtures were separated by electrophoresis on SDS-10% gels, blotted, autoradiographed, and subsequently stained with crafVII antiserum by using the ECL system. Lane co. contains MEK Ϫ alone. GNX exhibited constitutive kinase activity, which was enhanced by coexpression of PKC␣ and downregulated by simultaneous coexpression of PKA. The kinasenegative RafK357W mutant did not show activity under any conditions. The RafS621D mutant displayed a very weak induction of activity when coexpressed with PKC␣, which appeared resistant to downregulation by PKA. (B and C) Kinase activity of Raf-1 mutated at arginine 618, serines 619, or 621. Raf-1 and mutants were cloned into the pCMV5 vector and transiently expressed in COS-1 cells. Where indicated, PKA was cotransfected (ϩA). Two days posttransfection cells, were serum starved overnight (st.) and stimulated with EGF plus TPA (ϩE) for 15 min. Raf proteins were immunoprecipitated and examined for catalytic activity in the coupled kinase assay. Samples were resolved on SDS-10% gels and transferred to nitrocellulose. The blots were autoradiographed and subsequently stained with c-rafVII antiserum. The regulation of the RafS619A mutant was similar to that of wild-type Raf-1. The activities of both proteins were massively induced by mitogens and downregulated by PKA. In contrast, the RafS621A, RafS621C, and RafR618F mutants did not show activity exceeding the background level observed in vector-transfected cells. The background activity was due to endogenous Raf-1, which is clearly detectable on longer exposures of the Western blots shown but is expressed at a level about 10-fold lower than that of the transfected Raf-1 proteins.
FIG. 5. Deactivation of GNX by autophosphorylation. (A)
GNX was incubated in kinase buffer in the presence or absence of 20 M ATP for the time spans indicated. One-fifth of this reaction mixture was tested for the ability to phosphorylate MEK Ϫ . The kinase activity of GNX preincubated without ATP remained stable, whereas that of GNX preincubated with ATP progressively declined. (B) The kinetics of autophosphorylation on serine 621 were measured by parallel preincubation of GNX in the presence of [␥-
32 P]ATP. These samples were loaded onto SDS-10% gels. GNX bands were visualized by Coomassie staining, which showed equal loading. Gel slices corresponding to GNX were cut out, digested with trypsin, and processed for two-dimensional phosphopeptide mapping. The equivalent of one-fifth of each band was loaded onto a thin-layer plate. Autophosphorylation became detectable after 20 min of ATP incubation and increased up to 90 min. (C) GNX was allowed to autophosphorylate for 90 min and subsequently incubated with a mixture of PP1 and PP2A (3 PPs) or buffer. The phosphatase reaction was terminated by addition of calyculin, and the GNX kinase activity was tested with MEK Ϫ as the substrate. Lane Co. contains a kinase reaction mixture from which GNX was omitted. (D) In parallel, GNX was permitted to autophosphorylate for 90 min in the presence of [␥-32 P]ATP and then incubated with phosphatases where indicated (3 PPs). GNX was gel purified and digested with trypsin. Two-dimensional resolution of phosphopeptides revealed the autophosphorylation of serine 621 and the dephosphorylation of this residue by the phosphatases. (also see Fig. 6A ). This is due to the fact that a fraction of Raf proteins is phosphorylated on serine 621 in Sf-9 and mammalian cells (37) . To further investigate the relevance of serine 621 phosphorylation, GNX was expressed in Sf-9 cells alone or together with PKAcat and the Lck tyrosine kinase (Fig. 6A) . Src family kinases including Lck have been previously shown to activate Raf-1 by tyrosine phosphorylation in vitro and in vivo (4, 15, 19, 29, 51) . GNX was purified by binding to glutathione-Sepharose beads. Immobilized GNX was subsequently treated with PPs or the unspecific calf intestinal phosphatase (CIP). After extensive washes to remove the phosphatases, the GNX beads were resuspended in Raf kinase buffer and incubated with MEK Ϫ and [␥- To determine which residues were dephosphorylated by PPs, GNX alone was expressed in Sf-9 cells, immobilized on glutathione-Sepharose, phosphorylated by purified Src and PKA in vitro, and exposed to PPs as indicated. GNX was gel purified, digested with trypsin, and subjected to two-dimensional phosphopeptide analysis (Fig. 6B) . Tryptic peptides derived from GNX phosphorylated by Src resolved into five major spots. One spot corresponded to the peptide containing serine 621 and probably was contributed by GNX autophosphorylation. This spot was enhanced by PKA (2.7-fold, as determined by PhosphorImager quantitation) but was selectively reduced (4.7-fold) by PPs. The dephosphorylation of serine 621 was reflected in the increase of GNX catalytic activity (Fig. 6A) , providing further evidence that PKA inhibits Raf-1 by phosphorylation of serine 621.
DISCUSSION
We have investigated the molecular basis for the inhibition of Raf-1 by PKA. Raf-1 is activated by numerous growth fac- FIG. 6 . Dephosphorylation of serine 621 reverses the inhibitory effect of PKA. (A) GNX was expressed in Sf-9 cells alone (w/o) or together with the Lck tyrosine kinase (ϩLck). PKA was coexpressed where indicated (ϩ). GNX immobilized on glutathione-Sepharose beads was treated with a mixture of PP1 and PP2A (ϩPPs) or CIP (ϩCIP). After extensive washes to remove phosphatases, GNX kinase activity was tested with MEK Ϫ as the substrate. Lane MEK Ϫ contained MEK Ϫ alone. Samples were resolved on SDS-10% gels, blotted, autoradiographed, and stained with c-rafVII antiserum. Coexpression of Lck activated GNX, whereas coexpression of PKA decreased both the constitutive and induced kinase activities. Treatment with PPs alleviated the inhibitory effects of PKA, while the nonspecific phosphatase CIP reduced GNX activity under all conditions. (B) Phosphopeptide maps of GNX. GNX was immobilized on glutathione-Sepharose and phosphorylated with purified Src, PKA, or Src followed by PKA. The samples were split, and one aliquot was further treated with PPs. Between phosphorylation-dephosphorylation reactions, the samples were washed twice with TBST and the appropriate buffers. GNX proteins were gel purified, digested with trypsin, and subjected to two-dimensional separation.
VOL. 16, 1996 Raf- (9, 20, 31, 50) . This role of Raf-1 as a crucial interface for the integration of mitogenic signals is underscored by the fact that Raf-1 is also targeted by inhibitory pathways. PKA is the first and to date the sole inhibitor of Raf-1 kinase reported. PKA phosphorylates Raf-1 on several sites, which are predominantly located in the regulatory domain (19) . These phosphorylations can inhibit Raf-1 by two independent modes. First, PKA phosphorylation diminishes the affinity of Raf-1 for activated (GTP-loaded) Ras, thereby presumably interfering with Ras-dependent activation of Raf-1 (5, 19, 52) . Second, PKA suppresses the catalytic activity of Raf-1 by direct phosphorylation of the Raf-1 kinase domain (19) . All previous studies used drugs which directly or indirectly raise cAMP levels in the cell. This results in activation of PKA, but the second-messenger cAMP has also been shown to affect the activity of ion channels and transporter proteins independent of PKA (33, 40, 48) . Therefore, it was important to test whether the inhibitory effects of cAMP on Raf-1 signalling in the cell are indeed exerted by PKA. Expression of PKAcat could fully reproduce the inhibition of Raf-1 in COS-1 and Sf-9 cells, demonstrating that PKA is responsible for the suppression of Raf-1 in cells in response to cAMP agonists.
Furthermore, the relevant mechanism that mediates Raf-1 inhibition by PKA in the cell is not completely understood. The fact that v-raf transformation, which is Ras independent, could be reversed by drugs which elevate the cAMP levels in the cell point to the paramount role of the inhibition of the Raf-1 kinase domain by PKA (19) . This hypothesis is further substantiated by the present work. A Raf-1 mutant, which is defective for Ras binding as a result of the exchange of arginine 89 to leucine (RafR89L), could still be activated by treating cells with EGF and TPA, albeit to a lesser extent than wildtype Raf-1, and was susceptible to downregulation by PKA to the same extent as wild-type Raf-1. This finding demonstrates that the Raf-1 kinase activity can be regulated independent of Ras. At present it is unclear how this is accomplished, but these findings are in line with recent genetic data for the Drosophila system, which demonstrated that the torso receptor tyrosine kinase can activate Raf-1 by a Ras-independent pathway (22) . Likewise, BXB expressed in T cells was shown to be regulated by TPA or activation of the T-cell receptor (49) . Our data further indicate that the attenuation of Ras binding is not the decisive step in suppression of Raf-1 activity by PKA.
Therefore, we mapped the PKA phosphorylation site in the Raf-1 kinase domain. As shown by two-dimensional separation of phosphopeptides, PKA phosphorylated one tryptic peptide in the Raf-1 kinase domain. Using HPLC-MS, we identified the tryptic peptide SASEPSLHR (aa 619 to 627) as the PKA target. The detected masses indicated that this peptide was phosphorylated on a single site. The MS mapping data were refined by mutation of serines 619, 621, and 624 to alanines in the context of E. coli-expressed GNX. Change of serine 621 to alanine virtually abolished the phosphorylation of GNX by PKA in vitro, defining serine 621 as the major PKA phosphorylation site in the Raf-1 kinase domain. Serine 621 has been previously reported to be constitutively phosphorylated in Raf-1 proteins expressed in Sf-9 insect cells and mouse fibroblasts. Mutation of this residue to alanine resulted in a loss of Raf-1 kinase activity, leading to the suggestion that phosphorylation of serine 621 is a prerequisite for Raf-1 kinase activity (37) . Our results suggest that serine 621 is essential for Raf-1 kinase activity but that phosphorylation of this residue mediates the inhibition of Raf-1 kinase activity by PKA. A RafS621D mutant expressed in Sf-9 cells was heavily compromised in its catalytic activity, but the residual kinase activity was refractory to PKA downregulation. Raf-1 mutants in which S-621 was replaced by alanine or cysteine did not display kinase activity above the background level when expressed in COS-1 cells. Similarly, ablation of the consensus motif mutation for PKA phosphorylation by mutating arginine 618 yielded a kinase-dead Raf-1 mutant.
It has been suggested that the Raf-1 domain surrounding serine 621 constitutes a region which might be extraordinarily sensitive to alterations in structure imposed by mutations (37) . The fact that a RafS619A mutant behaves like wild-type Raf-1 in terms of activation and downregulation by PKA indicates that the integrity of the R-618-X 2 -S-621 motif is important for Raf-1 function. For instance, it is plausible that the phosphorylation at serine 621 could regulate substrate binding. This does not seem to be the case, however, as both the RafS621A and RafS621D mutants were not compromised in the ability to associate with MEK (39) . A recent report indicated that the binding of 14-3-3 proteins to Raf-1 depends on a consensus sequence defined by an arginine followed by a phosphoserine in the Ϫ3 position, R-X-X-pS (38) . Arginine 618 and serine 621 exactly match this motif, and the RafS621D mutant expressed in Sf-9 cells indeed exhibited a diminished ability to bind 14-3-3␤ (39). 14-3-3 proteins have been reported as positive modulators of Raf-1 (reviewed in reference 36). This effect of 14-3-3 proteins may be due to the protection of Raf-1 from inactivating phosphatases (11), including tyrosine phosphatases (13). 14-3-3 proteins, however, are not required for Raf-1 function (28, 34) and can also bind to Raf-1 via serine 259 in the regulatory domain (38, 41) . Binding is much stronger to the regulatory domain than to the catalytic domain (28) . These properties of the Raf-1-14-3-3 interaction cannot explain the regulatory role of serine 621 or the phenotype of the RafS621 mutants. Alternatively, this region may interact with a cofactor that is essential for kinase activity. The binding of such a hypothetical cofactor should require arginine 618 and serine 621 and is predicted to be inhibited by phosphorylation of serine 621. We cannot, however, discount the possibility that mutation of arginine 618 or serine 621 induces a conformation change that is incompatible with catalytic function.
The functional relevance of the phosphorylation status of serine 621 was demonstrated by two types of complementary experiments, first by showing that GNX autophosphorylates at serine 621. Although this autophosphorylation is inefficient and slow, its stoichiometry correlates well with the inhibition of kinase activity. Autophosphorylation at serine 621 starts to become detectable after 20 min, a time frame which is compatible with the activation kinetics of Raf-1 in mitogen-stimulated cells, in which case Raf-1 activity usually peaks within the first 5 to 15 min. Autophosphorylation thus may serve as an intrinsic mechanism to shut down the activated Raf-1 kinase. The more efficient phosphorylation of serine 621 by PKA enhances the downregulation of Raf-1 or even prevents activation. More importantly, dephosphorylation of serine 621 could relieve the PKA-mediated suppression of both the basal and the induced GNX kinase activity. Although the serine/threonine-specific phosphatases PP1 and PP2A have been reported to deactivate Raf-1 (11), the literature is not entirely clear on this issue (14, 46) . Previous publications stated that neither phosphatase was able to inactivate Raf-1. These discrepancies may in part be related to the different grades of purification of Raf-1 preparations used, since Dent et al. (11) could show that the Raf-1-associated protein 14-3-3 protects Raf-1 from inactivation by phosphatases. The GNX preparations used in our study contained only minute amounts of 14-3-3 proteins, which obviously were not able to prevent the substantial dephosphor-ylation of serine 621 in the experiments shown in Fig. 6 . Our results are difficult to compare with those of the previous studies, because these reports did not describe phosphorylation experiments or provide phosphopeptide maps to indicate which residues were actually dephosphorylated by PP1 and PP2A.
We have identified serine 621 as a phosphorylation site in the Raf-1 kinase domain, which exerts the inhibition of the Raf-1 catalytic activity by PKA. Given the high conservation of this residue between the different Raf isozymes, it will be instructive to examine whether PKA also inhibits A-Raf and B-Raf by phosphorylation of sites analogous to serine 621.
